These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1831860)

  • 21. Alterations of vasoconstrictor and sodium-regulating hormone systems in vascularly decompensated liver cirrhosis.
    Tulassay T; Tulassay Z; Büki B; Szathmári M; Rascher W
    Acta Med Hung; 1988; 45(1):73-81. PubMed ID: 2970621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of atrial natriuretic peptide (ANP) during mineralocorticoid escape in normal man.
    Wambach G; Götz S; Suckau G; Kaufmann W
    Klin Wochenschr; 1986; 64 Suppl 6():53-7. PubMed ID: 2948064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial natriuretic factor and liver disease.
    Warner L; Skorecki K; Blendis LM; Epstein M
    Hepatology; 1993 Mar; 17(3):500-13. PubMed ID: 8444424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma concentrations of atrial natriuretic hormone in acromegaly: relationship to hypertension.
    Soszyński P; Slowińska-Srzednicka J; Zgliczyński S
    Acta Endocrinol (Copenh); 1991 Sep; 125(3):268-72. PubMed ID: 1835235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
    Leehey DJ; Gollapudi P; Deakin A; Reid RW
    J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal and stimulated plasma atrial natriuretic factor in type 2 diabetes.
    McKnight JA; Sheridan B; Roberts G; Atkinson AB
    Diabetes Res; 1991 Nov; 18(3):143-8. PubMed ID: 1841825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium and phosphorus metabolic changes in children with hepatic bilharziasis.
    Hafez M; Mohareb SW; Hafez TA; Fahmi HA; Kassem AS; El Nahhas MR; El-Nady A
    Gaz Egypt Paediatr Assoc; 1975; 23(3-4):243-52. PubMed ID: 1230349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutual interaction of the renin-angiotensin system and the atrial natriuretic factor in the renal response to acute volume loading].
    Horký K; Tesar V; Gregorová I; Srámková J; Dvoráková J
    Vnitr Lek; 1990 Jul; 36(7):625-32. PubMed ID: 2147304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
    Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G
    Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atrial natriuretic factor. Initial results of possible significance in liver cirrhosis].
    Gerbes AL; Arendt RM; Sauerbruch T; Paumgartner G
    Leber Magen Darm; 1987 Dec; 17(6):393-404. PubMed ID: 2963183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites.
    Jiménez W; Gutkowska J; Ginés P; Arroyo V; Rivera F; Rodés J
    Hepatology; 1991 Oct; 14(4 Pt 1):601-7. PubMed ID: 1833302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Reaction of the cardiovascular and humoral system to acute hypervolemia in patients with liver cirrhosis].
    Kozáková M; Tesar V; Petrtýl J; Horký K; Kordac V
    Cas Lek Cesk; 1989 Feb; 128(6):168-73. PubMed ID: 2524257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous radio-isotopic study of both fibrinogen and platelets in hepatic schistosomiasis.
    Tewfik SA; el-Sawy MM; Abaza MH; Sidrak MS; Mikhail MM; Ziada LE; Shaala IY
    J Trop Med Hyg; 1987 Jun; 90(3):143-7. PubMed ID: 3586094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acute water loading on plasma levels of antidiuretic hormone AVP aldosterone, ANP fractional excretion of sodium and plasma and urine osmolalities in myxedema.
    Bai Y; Liu XM; Guo ZS; Dai WX; Shi YF; Zhou XY
    Chin Med J (Engl); 1990 Sep; 103(9):704-8. PubMed ID: 2147645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal sodium retention during upright posture in preascitic cirrhosis.
    Bernardi M; Di Marco C; Trevisani F; Fornalè L; Andreone P; Cursaro C; Baraldini M; Ligabue A; Tamè MR; Gasbarrini G
    Gastroenterology; 1993 Jul; 105(1):188-93. PubMed ID: 8514034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immuno-metabolic factors in schistosomal hepatic fibrosis modulating atherogenesis.
    Assaad-Khalil SH; Lachine N; Sidrak M; Amara F; Jacotot B; Fahmy MH
    Ann Biol Clin (Paris); 1992; 50(10-11):697-701. PubMed ID: 1306953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of chemical constituents of thoracic duct lymph in schistosomal hepatic fibrosis.
    Sadek AM; Guirgis FK; Ayad W; El-Sawy M; Ismal A; Abdel-Hay MM
    Ann Trop Med Parasitol; 1978 Apr; 72(2):139-43. PubMed ID: 666385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein content of thoracic duct lymph in patients with bilharzial hepatic fibrosis.
    El-Zawahry MD; El-Roubi OA; Ibrahim AS
    Gastroenterology; 1977 Apr; 72(4 Pt 1):617-20. PubMed ID: 838214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.